FindTrial
Sign In

Studying for presence of Glaucoma in Different Stages of Diabetic Eye Disease: A research study.

Evaluation for Glaucoma in Mild, Moderate and Severe Non-Proliferative Diabetic Retinopathy - A Prospective Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065066
Enrollment
150
Registered
2024-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa

Interventions

Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL Control Intervention3: Visual field analysis: OCT of retinal layer , optic disc , ganglion cell layer

Sponsors

Ishita kak
Lead Sponsor
Centre for sight eye institute Dwarka
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Mild moderate severe NPDR with or without macular edema with vision greater than 6 by 24 , post intravitreal injections, post focal laser , none treatment

Exclusion criteria

Exclusion criteria: Advanced glaucoma Co-existing macular ischemia Co-existing juxtafoveal telangiectasia Proliferative Diabetic Retinopathy Retinal Dystrophy and Degeneration Optic atrophy Post Vitero-Retina surgeries Associated CRAO BRAO BRVO CRVO Past History of uveitis diabetic papillopathy papilloedema History of Trauma Cataract PCO Myopia Amblyopia

Design outcomes

Primary

MeasureTime frame
To find the Incidence of Glaucoma in mild, moderate and severe Non Proliferative Diabetic RetinopathyTimepoint: At the end of 24 months—

Secondary

MeasureTime frame
To determine sensitivity & specificity of various standard diagnostic tests viz a viz optic nerve head findings Pachymetry Automated Visual Field Tesing & OCT Retinal Nerve Fiber Layer Ganglion Cell Complex for Glaucoma diagnosis in NPDR patientsTimepoint: At the end of 26 months—

Countries

India

Contacts

Public ContactMaj Gen Dr Sagarika Patyal

Centre for sight eye institute

sagarikapatyal@gmail.com9643437024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026